Henry M, Thomas K, Ross I
Front Endocrinol (Lausanne). 2021; 12:694046.
PMID: 34512546
PMC: 8429905.
DOI: 10.3389/fendo.2021.694046.
Rao R, Somvanshi P, Klerman E, Marmar C, Doyle 3rd F
Metabolites. 2021; 11(8).
PMID: 34436424
PMC: 8400645.
DOI: 10.3390/metabo11080483.
Kinlein S, Karatsoreos I
Front Neuroendocrinol. 2019; 56:100819.
PMID: 31863788
PMC: 7643247.
DOI: 10.1016/j.yfrne.2019.100819.
Karatsoreos I
Curr Top Behav Neurosci. 2019; 43:323-351.
PMID: 31586337
PMC: 7594017.
DOI: 10.1007/7854_2019_115.
Wright Jr K, Drake A, Frey D, Fleshner M, DeSouza C, Gronfier C
Brain Behav Immun. 2015; 47:24-34.
PMID: 25640603
PMC: 5401766.
DOI: 10.1016/j.bbi.2015.01.004.
Consuming more of daily caloric intake at dinner predisposes to obesity. A 6-year population-based prospective cohort study.
Bo S, Musso G, Beccuti G, Fadda M, Fedele D, Gambino R
PLoS One. 2014; 9(9):e108467.
PMID: 25250617
PMC: 4177396.
DOI: 10.1371/journal.pone.0108467.
Role of circadian neuroendocrine rhythms in the control of behavior and physiology.
Urbanski H
Neuroendocrinology. 2011; 93(4):211-22.
PMID: 21508622
PMC: 3128131.
DOI: 10.1159/000327399.
Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity.
Balbo M, Leproult R, Van Cauter E
Int J Endocrinol. 2010; 2010:759234.
PMID: 20628523
PMC: 2902103.
DOI: 10.1155/2010/759234.
Specific effects of escitalopram on neuroendocrine response.
Hawken E, Owen J, Hudson R, Delva N
Psychopharmacology (Berl). 2009; 207(1):27-34.
PMID: 19662384
DOI: 10.1007/s00213-009-1633-1.
Complex rhythmicity of growth hormone secretion in humans.
Surya S, Symons K, Rothman E, Barkan A
Pituitary. 2006; 9(2):121-5.
PMID: 16845601
DOI: 10.1007/s11102-006-9079-5.
The regulation of neuroendocrine function: Timing is everything.
Kriegsfeld L, Silver R
Horm Behav. 2006; 49(5):557-74.
PMID: 16497305
PMC: 3275441.
DOI: 10.1016/j.yhbeh.2005.12.011.
Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.
Mahmood I, Green M
Clin Pharmacokinet. 2005; 44(4):331-47.
PMID: 15828849
DOI: 10.2165/00003088-200544040-00001.
The relevance of pharmacokinetics in the development of biotechnology products.
Toon S
Eur J Drug Metab Pharmacokinet. 1996; 21(2):93-103.
PMID: 8839682
DOI: 10.1007/BF03190257.
Clomipramine-induced sleep disturbance does not impair its prolactin-releasing action.
Follenius M, Spiegel K, Gronfier C, Saini J, Brandenberger G
J Endocrinol Invest. 1994; 17(6):417-23.
PMID: 7930386
DOI: 10.1007/BF03347728.
Twenty-four-hour profiles and sleep-related variations of cortisol, thyrotropin and plasma renin activity in healthy African melanoids.
Goichot B, Buguet A, Bogui P, Montmayeur A, Bourdon L, Dumas M
Eur J Appl Physiol Occup Physiol. 1995; 70(3):220-5.
PMID: 7607196
DOI: 10.1007/BF00238567.
Nocturnal oscillations of plasma aldosterone in relation to sleep stages.
Krauth M, Saini J, Follenius M, Brandenberger G
J Endocrinol Invest. 1990; 13(9):727-35.
PMID: 1963435
DOI: 10.1007/BF03349609.
Growth hormone and cortisol secretion in relation to sleep and wakefulness.
Davidson J, Moldofsky H, Lue F
J Psychiatry Neurosci. 1991; 16(2):96-102.
PMID: 1911740
PMC: 1188300.
Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922.
Francheteau P, Steimer J, Dubray C, Lavene D
J Pharmacokinet Biopharm. 1991; 19(3):287-309.
PMID: 1875283
DOI: 10.1007/BF03036252.
Nocturnal prolactin pulses in relation to luteinizing hormone and thyrotropin.
Saini J, Simon C, Brandenberger G, WITTERSHEIM G, Follenius M
J Endocrinol Invest. 1992; 15(10):741-7.
PMID: 1491122
DOI: 10.1007/BF03347644.